Author: <span>Fran Mannino</span>
asbestos exposure, Clinical Trials/Research/Emerging Treatments, Mesothelioma News

Study: Those Exposed to Asbestos Should Not Take Beta-Carotene

 

Taking beta-carotene health supplements could increase the risk of lung cancer or death from cardiovascular disease for anyone who is regularly exposed to asbestos, according to a panel of medicine experts. Based on existing scientific evidence, the U.S. Preventive Services Task Force concluded recently that the potential harms of beta-carotene supplements outweigh any benefits, particularly […]

The post Study: Those Exposed to Asbestos Should Not Take Beta-Carotene appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Awareness/Advocacy, mesothelioma, Mesothelioma News, Peritoneal, Pleural, Treatment

MARF to Host International Symposium on Malignant Mesothelioma

 

Leading medical specialists will gather with mesothelioma patients, families, friends and advocates at the much-anticipated 2022 International Symposium on Malignant Mesothelioma, July 23, in Chicago. This is an event well worth attending. The day-long symposium will be held at Summit Chicago, a welcoming venue where a wide range of mesothelioma experts will be speaking on […]

The post MARF to Host International Symposium on Malignant Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

asbestos exposure, mesothelioma, Mesothelioma News

New Study Underscores Importance of Worldwide Asbestos Ban

 

The push for a worldwide ban on asbestos gained momentum recently with the latest study linking national consumption levels of the toxic mineral with corresponding levels of asbestos-related diseases. An ecological association between asbestos and asbestos-related diseases was made in 70 countries, doubling the number found in a similar study released in 2007. Environmental Health […]

The post New Study Underscores Importance of Worldwide Asbestos Ban appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Clinical Trials/Research/Emerging Treatments, Mesothelioma News, Pleural

Researchers in Japan Study Inhalable Gene Therapy for Mesothelioma

 

Patients with malignant pleural mesothelioma may be turning to orally inhalable gene therapy in the future, easing the treatment burden for this cancer with no cure. The recent focus on identifying genetic mutations that make individuals more susceptible to certain cancers – including mesothelioma – has led to related research on how best to combat […]

The post Researchers in Japan Study Inhalable Gene Therapy for Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Clinical Trials/Research/Emerging Treatments, mesothelioma, Mesothelioma News

Drug Repurposing Study Could Identify New Mesothelioma Treatments

 

The next breakthrough in the treatment of malignant mesothelioma may be quietly underway. An international research team based at Temple University in Philadelphia recently identified four drug compounds – already being used safely for noncancerous conditions – that have shown impressive potential for treating mesothelioma. They were part of a novel drug repurposing project aimed […]

The post Drug Repurposing Study Could Identify New Mesothelioma Treatments appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

asbestos exposure, Mesothelioma News

EPA Finalizes Asbestos Risk Evaluation Goals with Part 2 Assessment

 

Utilizing recent public feedback, the U.S. Environmental Protection Agency finalized its strategy and goals for the much-anticipated Risk Evaluation for Asbestos Part 2. Its final scope document, released June 29, clarified the EPA’s intentions, which will build on the previously released and much-maligned Part 1. A broader Part 2 will be published late in 2024. […]

The post EPA Finalizes Asbestos Risk Evaluation Goals with Part 2 Assessment appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Clinical Trials/Research/Emerging Treatments, Mesothelioma News

Toronto Cancer Center Hosts SMARTEST Mesothelioma Clinical Trial

 

Princess Margaret Cancer Centre in Toronto recently opened a first-of-its-kind clinical trial that hopes to build on earlier pioneering efforts to turn pleural mesothelioma into a more manageable, potentially survivable disease. Expectations are high. This single-center phase II clinical trial is named SMARTEST, and follows in the wake of earlier mesothelioma trials SMART and SMARTER […]

The post Toronto Cancer Center Hosts SMARTEST Mesothelioma Clinical Trial appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Clinical Trials/Research/Emerging Treatments, Mesothelioma News

Mesothelioma Clinical Trials Test Targeted Gene Therapy

 

For some patients, the future of mesothelioma cancer treatment may hinge on a pair of phase I clinical trials that opened earlier this year to study promising new drugs targeting specific genetic mutations. Precision medicine may finally be taking hold with malignant mesothelioma, clearing the path for significant, long-overdue advancements. The one-size-fits-all approach is fading. […]

The post Mesothelioma Clinical Trials Test Targeted Gene Therapy appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Clinical Trials/Research/Emerging Treatments, Mesothelioma News

New Mesothelioma Immunotherapy Clinical Trial Opens at MD Anderson

 

The acclaimed MD Anderson Cancer Center in Houston is opening a phase II clinical trial involving a new immunotherapy drug aimed specifically at advanced, rare cancers, including both pleural and peritoneal mesothelioma. This single-institution clinical trial will be measuring the safety and effectiveness of vudalimab, also known as XmAb20717, which was designed by the California-based […]

The post New Mesothelioma Immunotherapy Clinical Trial Opens at MD Anderson appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

asbestos exposure, Mesothelioma News

Johnson & Johnson To Continue Global Sale of Talc-Based Baby Powder

 

Johnson & Johnson will continue selling its iconic talc-based baby powder outside the United States and Canada after shareholders rejected a proposal that would have ended its worldwide production and distribution. The proposal failed to receive the majority vote needed at J&J’s annual meeting of stockholders last month, which was held virtually due to the […]

The post Johnson & Johnson To Continue Global Sale of Talc-Based Baby Powder appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Mesothelioma News, Pleural, Treatment

Heated Intrathoracic Chemotherapy Could Extend Mesothelioma Survival

 

Patients with pleural mesothelioma undergoing aggressive surgery should consider combining it with controversial hyperthermic intrathoracic chemotherapy to extend survival, according to a recent study. Although the procedure, also known as HITHOC, has yet to be proven effective in a randomized clinical trial – and still is being debated by mesothelioma specialists – the report has […]

The post Heated Intrathoracic Chemotherapy Could Extend Mesothelioma Survival appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

asbestos exposure, Mesothelioma News

United Kingdom Proposes 40-Year Asbestos Removal Deadline

 

The United Kingdom’s Work and Pensions Committee has proposed a 40-year timeline to complete the regulated removal of all long-standing legacy asbestos from public and commercial buildings, potentially setting a new standard for other nations to follow. Its proposal was recently delivered to the House of Commons with a recommendation that the government and Health […]

The post United Kingdom Proposes 40-Year Asbestos Removal Deadline appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Mesothelioma News, Treatment

Peritoneal Mesothelioma HIPEC Program Comes to Alabama

 

Patients in Alabama diagnosed with peritoneal mesothelioma cancer no longer need to leave the state in pursuit of optimal care and long-term survival. The best possible mesothelioma treatment is now closer to home. The O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham recently launched a complex treatment program for several abdominal malignancies […]

The post Peritoneal Mesothelioma HIPEC Program Comes to Alabama appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Legal, Mesothelioma News

Johnson & Johnson Bankruptcy Plan Won’t Halt Industrial Talc Lawsuit

 

Johnson & Johnson may have used a controversial bankruptcy spinoff to avoid almost 40,000 cosmetic talc lawsuits, but it now must face plaintiffs harmed by industrial talcum powder decades ago. U.S. federal Judge Michael Kaplan ruled earlier this month that the recent bankruptcy plan halting the majority of cases would not apply to this latest […]

The post Johnson & Johnson Bankruptcy Plan Won’t Halt Industrial Talc Lawsuit appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Clinical Trials/Research/Emerging Treatments, Mesothelioma News

Study Finds Benefits to Second Peritoneal Mesothelioma Surgery

 

Patients with peritoneal mesothelioma cancer can survive considerably longer if they are willing and able to undergo a second aggressive surgery following tumor recurrence. History has proven that an incentive for a repeat surgery is there. A recent 30-year retrospective review at Wake Forest Baptist Medical Center has shown how beneficial the combination of cytoreductive […]

The post Study Finds Benefits to Second Peritoneal Mesothelioma Surgery appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.